PATENT CLAIM ANALYSIS

Application Number: 16268344
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-07
Patent Classification: ["424", "185100"]

Abstract:
The invention relates to producing humoral response to P2X7 receptors in individuals having cancer, and to minimising the progression of cancer in said individuals.

Claim (Index 17):
A process for forming a humoral immune response to cancer-associated P2X 7  receptors in an individual who has received a therapy for cancer, including the steps of:\n forming an immune response in the individual by administering to the individual P2X 7  receptor that is unable to form an apoptotic pore, or one or more sites unable to bind ATP, or a monomer or fragment thereof; wherein the P2X 7  receptor, monomer or fragment thereof is capable of inducing an antibody response in the individual, wherein the immune response is formed in the individual at a time where the anti-cancer treatment of cancer received by the individual is at a level or concentration that is substantially undetectable in the individual; and/or the humoral immune response to cancer-associated P2X 7  receptors is formed according to an immunisation schedule whereby the amount of antibody formed in the individual to cancer-associated P2X 7  receptor is about 0.1 to 25 mg/kg individual.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 99.0
- Lexical Diversity: 1.2381
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15399337', '14129240', '15085929', '13002647', '15910987']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7406861082608814
- 35 USC 102 Novelty (BERT): 0.5755373609992158
- Combined Prediction Score: 0.7241712335347148
- Mean Citation Score: 365.366668
- Max Citation Score: 482.1742
- Similarity Product: 395.4080453750372

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test